Bruce A. Cooper

A Metabolomics Approach for Early Prediction of Vincristine-Induced Peripheral Neuropathy

Elizabeth M. Wells, Lang Li, D. Ramkrishna, 2019, Scientific Reports.

A Metabolomics Approach for Early Prediction of Vincristine-Induced Peripheral Neuropathy

Elizabeth M. Wells, Lang Li, D. Ramkrishna, 2020, Scientific Reports.

Metabolites produced during the growth of probiotics in cocoa supplementation and the limited role of cocoa in host-enteric bacterial pathogen interactions

U. Aryal, M. Peng, D. Biswas, 2015 .

Development of a Pediatric Mini-Tablet Formulation for Expedited Preclinical Studies

G. Knipp, Monika Lavan, S. Byrn, 2021, AAPS PharmSciTech.

Identification of brain‐targeted bioactive dietary quercetin‐3‐O‐glucuronide as a novel intervention for Alzheimer's disease

J. Simon, G. Pasinetti, S. Percival, 2013, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

Brain-Targeted Proanthocyanidin Metabolites for Alzheimer's Disease Treatment

Sara M. Levens, A. Kania, S. Perlmutter, 2012, The Journal of Neuroscience.

Tolerance of chronic HDACi-administration used for treatment of neurological and visceral disease including lung pathogenesis

K. Haldar, Bruce A. Cooper, Md. Suhail Alam, 2017, bioRxiv.

Identification of brain‐targeted bioactive dietary quercetin‐3‐O‐glucuronide as a novel intervention for Alzheimer's disease

G. Pasinetti, S. Percival, L. Ho, 2013, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

Brain-Targeted Proanthocyanidin Metabolites for Alzheimer's Disease Treatment

R. Dixon, C. Pavlides, D. Teplow, 2012, The Journal of Neuroscience.

The impact of treatment with avacopan on health-related quality of life in antineutrophil cytoplasmic antibody-associated vasculitis: a post-hoc analysis of data from the ADVOCATE trial.

F. Pieruzzi, B. Rovin, V. Strand, 2023, The Lancet. Rheumatology.